Elevance Health: evp & cfo Mark Kaye sold 10,584 shares

What happened

• The filing says Mark Kaye, evp & cfo, sold 10,584 shares of Elevance Health in open-market transactions on Oct 22, 2026. The reported proceeds total $4,658,357. The Form 4 was filed on Oct 23, 2026.

Key details

• Transaction date: Oct 22, 2026. All transactions reported as sales (code S).
• Reported prices: sales executed in multiple trades at prices ranging from $433.54 to $447.27; reported prices are weighted averages per sale.
• Number of sale entries: 13 separate sale line items totaling 10,584 shares and $4,658,357 in proceeds.
• Shares owned after the transactions: not included in the supplied filing summary.
• Footnotes: the filing includes footnotes (F1–F13) stating each sale was executed in multiple trades at the indicated price ranges and that the reporting person will provide full trade-level details upon request.
• Timeliness: the Form 4 was filed the day after the transactions (filed Oct 23, 2026 for Oct 22, 2026 transactions).

Why it may matter

• The filing shows routine open-market sales; it does not report option exercises, gifts, 10% ownership changes, or tax-withholding transactions in the supplied summary.
• A filing does not show why the insider traded or why the company acted.